Molina Healthcare Forecasts Significant Profit Growth By 2029

Molina Healthcare projects a substantial increase in its 2029 adjusted profit compared to 2026, contingent upon effective management of medical costs. However, this optimistic outlook fell short of investor expectations, leading to a 5% decline in share value, as noted by analysts from J.P. Morgan and Barclays.

The significant earnings growth potential by 2029 highlights a promising trajectory, although investors focus on the assumptions underpinning this forecast. Leading health insurers like Molina, UnitedHealth, and Elevance reported strong first-quarter results, indicating a decline in healthcare service costs and an improvement in profit margins after an extended period of financial strain.

Molina forecasts its premium revenue to grow from $42 billion in 2026 to approximately $64 billion in 2029. It projects an adjusted profit range of $20 to $30 per share for 2029, a notable increase from a minimum of $5 per share in 2026. The company has adjusted its pre-tax margin target to 2% to 3% for 2029, down from 4% to 5%, yet Mizuho analyst Ann Hynes sees this as attainable. CEO Joe Zubretsky remains confident in the forecast, citing stabilization in medical cost trends and quicker alignment with government reimbursement rates. This includes an anticipated 2% to 3% yearly decrease in Medicaid plan enrollment, influenced by regulatory compliance requirements.